DCI Partners Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 25

  • Portfolio
  • 18

  • Exits
  • 6

Exits

DCI Partners General Information

Company Description

Founded in 2014, DCI Partners is a venture capital arm of Daiwa Corporate Investment based in Tokyo, Japan. The firm seeks to invest in business products, business services, healthcare, life sciences, and 3D printing sectors in Japan and Taiwan.

Business Details

Year Founded
2014
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • GranTokyo North Tower 1-9-1
  • Marunouchi, Chiyoda-ku
  • Tokyo
  • Japan
+81

DCI Partners Investments (25)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Apeximmune 01-Apr-2025 Later Stage VC Drug Discovery Generating Revenue
Rege Nephro 07-Oct-2024 Drug Discovery Clinical Trials - Phase 2
Luxna Biotech 06-Sep-2024 Biotechnology Generating Revenue
aceRNA Technologies 07-May-2024 Drug Discovery Generating Revenue
OrthoReBirth 28-Mar-2024 Other Devices and Supplies Generating Revenue
C4U 17-May-2023 Discovery Tools (Healthcare) Startup
AdipoSeeds 12-Dec-2022 Discovery Tools (Healthcare) Clinical Trials - General
LUCA Science 01-Jun-2022 Biotechnology Pre-Clinical Trials
K Pharma 28-Apr-2022 Later Stage VC Drug Discovery Profitable
Vee Finance 13-Sep-2021 Early Stage VC Financial Software Out of Business
You’re viewing 10 of 25 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DCI Partners Exits (6)

Company Name Exit Date Exit Type Exit Size
Vee Finance 04-Nov-2024 Out of Business
PRISM BioLab 02-Jul-2024
K Pharma 17-Oct-2023
StemRIM 09-Aug-2019 IPO
SmartDM 07-Jan-2005 Merger/Acquisition
You’re viewing 5 of 6 exits. Get the full list »

DCI Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore DCI Partners‘s full profile, request access.

Request a free trial

DCI Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

DCI Partners FAQs

  • What is DCI Partners?

    Founded in 2014, DCI Partners is a venture capital arm of Daiwa Corporate Investment based in Tokyo, Japan.

  • When was DCI Partners founded?

    DCI Partners was founded in 2014.

  • Where is DCI Partners headquartered?

    DCI Partners is headquartered in Tokyo, Japan.

  • What is DCI Partners's total asset value?

    DCI Partners has around in total assets under management.

  • How many investments has DCI Partners made?

    DCI Partners has made 25 investments.

  • What has DCI Partners invested in?

    DCI Partners has made numerous investments in companies like Apeximmune, Rege Nephro, and Luxna Biotech within the Drug Discovery and Biotechnology industries.

  • What has DCI Partners invested in recently?

    DCI Partners's latest investment was on 01-Apr-2025 in Apeximmune, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »